Volumetric modulated arc therapy (VMAT) has been adopted by many clinics for its higher delivery efficiency compared to conventional intensity modulated radiotherapy techniques.Currently, the quality assurance (QA) has remained a challenge in that no identical tests are available for accelerators from different vendors. This study is the first attempt to design identical QA tests for the VMAT technique for Varian and Elekta machines. Identical procedures testing MLC positions and movements, dose rate variations, and gantry positions and movement were created for both machines. These included picket fence (PF), dose rate vs. gantry speed (DRGS) and MLC speed vs. dose rate (MLCDR) tests. Deliverable plans for these tests were made with in-house software that was deliverable for linacs from two ven-
dors (Elekta Synergy and Varian Trilogy). The electronic portal imaging device (EPID) wasused for these tests. An automated analysis method was established and software was created to quantitatively evaluate the result. The systematic gap position and width errors from PF tests were within 0.5 mm. We evaluated the detectability of this program for introduced errors down to 0.2 mm. Linear relationships existed between the introduced errors and measured errors. In the DRGS test, 99.8% and 100.0% of the intensity deviations from expected profiles were less than 3% for the Synergy and Trilogy, respectively. For the MLCDR, the intensity deviations from expected profiles less than 3% were 100.0% for Synergy and 98.1%for Trilogy. Identical test series were created and implemented for VMAT accelerators from two vendors. Test results were reported from both accelerators. Comparable results were obtained from both vendors, enabling uniform criteria to be established for VMAT quality assurance.Key words: EPID; QA; VMAT.
IntroductionRoutine use of volumetric modulated arc therapy (VMAT) in the clinic is spreading rapidly. VMAT shows higher delivery efficiency with similar or better dosimetric benefits compared to traditional intensity modulated radiotherapy (IMRT) (1, 2).At present, two venders (Elekta and Varian) provide VMAT capabilities. The current VMAT quality assurance (QA) procedure for both venders' linacs was investigated by many groups. Ling et al. designed a series to test and commission the RapidArc system (Varian, Palo Alto, CA) (3). After that, automatic electronic portal imaging device (EPID) based test procedures and related tolerance levels were established